Everolimus in de Novo Heart Transplant Recipients

Clinical trial NCT01017029 · COMPLETED

Trial details

NCT number: NCT01017029
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiac Transplantation

Start date: 2009-09-01
Primary completion: 2013-12-01
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.